✦ LIBER ✦

Pharmacokinetics and pharmacodynamics of locoregional 5 fluorouracil (5FU) in advanced colorectal liver metastases

✍ Scribed by Goldberg, JA; Kerr, DJ; Willmott, N; McKillop, JH; McArdle, CS

Book ID: 109836060
Publisher: Nature Publishing Group
Year: 1988
Tongue: English
Weight: 663 KB
Volume: 57
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1988.39

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and related therapeutic

Pharmacokinetics and related therapeutic results in regional 5-FU chemotherapy for colorectal liver metastases

✍ P. Hohenberger; K. Buhl; P. Schlag; H. Sinn 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 English ⚖ 137 KB

Hepatic arterial chemotherapy of 5 fluor

Hepatic arterial chemotherapy of 5 fluorouracil (5FU) combined with intravenous 5FU and folinic acid in patients with liver metastases of colorectal cancer

✍ Galais, M.P.; Sabate, J.M.; Boige, V.; Lebray, P.; Elias, D.; Lasser, P.; Ducreu 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 160 KB

The pharmacokinetics of 5-fluorouracil a

The pharmacokinetics of 5-fluorouracil administered by arterial infusion in advanced colorectal hepatic metastases

✍ Goldberg, JA; Kerr, DJ; Watson, DG; Willmott, N; Bates, CD; McKillop, JH; McArdl 📂 Article 📅 1990 🏛 Nature Publishing Group 🌐 English ⚖ 635 KB

760 Methotrexate (MTX) and 5-fluorouraci

760 Methotrexate (MTX) and 5-fluorouracil (5-FU) in advanced colorectal cancer patients previously treated with adjuvant 5-FU

✍ P. Pronzato; F. Vaira; A. Viganni; P. Losardo; G. Bertelli 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Intraperitoneal infusion of 5-FU in live

Intraperitoneal infusion of 5-FU in liver metastases from colorectal cancer

✍ Henrik Ekberg; Karl-Göran Tranberg; Bo Persson; Bengt Jeppsson; Lars-Göran Nilss 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

Intraperitoneal 5-fluorouracil (5-FU) was given to eight patients with unresectable colorectal liver cancer and to one patient after radical hepatectomy . A subcutaneous intraperitoneal access device was implanted, and treatment consisted of continuous infusion of 1,OOO mg 5-FU/d for 5 days, repeate

746 - Oxaliplatin (LOHP) and 5-fluoroura

746 - Oxaliplatin (LOHP) and 5-fluorouracil (5-FU) synergism in advanced colorectal cancer patients (ACRC)

✍ V. Meyer; R. Delva; E. Gamelin; B. Lamezec; P. Maillart; E. Danquechin-Dorval; A 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 261 KB